Skip to main content

Table 3 circRNAs and clinicopathological features of breast cancer

From: circRNAs and their relationship with breast cancer: a review

CircRNA

Expression in BC

Subtype of BC

Clinicopathological features

Number of cases

Ref.

Tumor size and TNM stage

Metastasis

IHC and subtype

Grade

Others

circSEPT9

↑

TNBC

T, N, TNM

    

60

[42]

hsa_circ_001783

↑

-

T, N, TNM

 

ER, PR, Ki-67, molecular subtype

  

136

[5]

circRNF20 (hsa_circ_0087784)

↑

-

tumor size

LN

   

50

[6]

hsa_circ_0005273

↑

–

tumor size, TNM

LN, distant

   

120

[34]

circACTN4

↑

Non-TNBC

T, N, TNM

    

240

[45]

hsa_circ_0001785

↑

–

TNM

Distant

 

Histological grade

 

57

[43]

circHMCU (hsa_circ_0000247)

↑

–

T, N

LN

ER, PR, HER2

Histological grade

 

267

[72]

circKIF4A (hsa_circ_0007255)

↑

TNBC

Tumor size, TNM

LN

   

240

[73]

circMMP11 (hsa_circ_0062558)

↑

–

TNM

LN

   

113

[74]

circEPSTI1 (hsa_circ_000479)

↑

TNBC

Tumor size, TNM

LN

   

240

[75]

circLARP4

↑

–

Tumor size, T, N, TNM

    

283

[76]

circPLK1 (has_circ_0038632)

↑

TNBC

Tumor size, TNM

LN

   

240

[75]

circRNA_100395

↓

–

T

    

52

[77]

hsa_circ_0025202

↓

HR-positive

BC

 

LN

 

Histological grade,

 

230

[39]

hsa_circ_0001073

↓

-

Tumor size

LN

  

age

132

[78]

  1. LN lymph node, IHC immunohistochemistry, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2